Curet Myriam insider trades
Curet Myriam has filed 63 Form 4s with the SEC that we hold, for Intuitive Surgical INC (ISRG) (EVP & Chief Medical Officer), Stereotaxis, Inc. (STXS) (Director), Inspire Medical Systems, Inc. (INSP) (Director) and Nektar Therapeutics (NKTR) (Director), among 5 companies in all. Across all of them we count 2 purchases worth $804 and 59 sales worth $51.4M reported on Form 4. In the last 12 months: 0 purchases ($0) and 16 sales ($8.4M). The largest single trade was a sale of 3,000 shares of Intuitive Surgical INC worth $3.2M, dated 2021-09-09. The first filing on our record is dated 2021-08-27 and the latest 2026-08-03.
Intuitive Surgical INC (ISRG)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-09-09 | S, sale reported on Form 4 | 3,000 | $3.2M | 2021-09-10 |
| 2021-09-09 | S, sale reported on Form 4 | 1,250 | $1.4M | 2021-09-10 |
| 2021-10-22 | S, sale reported on Form 4 | 6,000 | $2.0M | 2021-10-26 |
| 2022-01-25 | S, sale reported on Form 4 | 3,000 | $791.8K | 2022-01-26 |
| 2022-02-16 | S, sale reported on Form 4 | 2,478 | $716.1K | 2022-02-17 |
| 2022-03-01 | S, sale reported on Form 4 | 2,000 | $579.9K | 2022-03-02 |
| 2022-04-26 | S, sale reported on Form 4 | 6,000 | $1.5M | 2022-04-27 |
| 2022-07-27 | S, sale reported on Form 4 | 9,000 | $2.0M | 2022-07-28 |
| 2022-10-21 | S, sale reported on Form 4 | 6,000 | $1.3M | 2022-10-24 |
| 2022-10-21 | S, sale reported on Form 4 | 2,000 | $419.6K | 2022-10-24 |
| 2022-11-01 | S, sale reported on Form 4 | 2,000 | $500.1K | 2022-11-02 |
| 2022-11-01 | S, sale reported on Form 4 | 6,000 | $1.5M | 2022-11-02 |
| 2023-02-16 | S, sale reported on Form 4 | 1,124 | $270.6K | 2023-02-16 |
| 2023-03-01 | S, sale reported on Form 4 | 1,253 | $286.3K | 2023-03-01 |
| 2023-04-21 | S, sale reported on Form 4 | 505 | $151.5K | 2023-04-24 |
| 2023-04-21 | S, sale reported on Form 4 | 1,118 | $333.1K | 2023-04-24 |
| 2023-04-21 | S, sale reported on Form 4 | 6,000 | $1.8M | 2023-04-24 |
| 2023-04-21 | S, sale reported on Form 4 | 2,000 | $600.0K | 2023-04-24 |
| 2023-11-16 | S, sale reported on Form 4 | 2,819 | $845.7K | 2023-11-17 |
| 2023-11-16 | S, sale reported on Form 4 | 1,500 | $450.0K | 2023-11-17 |
| 2023-11-16 | S, sale reported on Form 4 | 4,500 | $1.4M | 2023-11-17 |
| 2024-01-26 | S, sale reported on Form 4 | 1,500 | $555.2K | 2024-01-29 |
| 2024-01-26 | S, sale reported on Form 4 | 2,818 | $1.0M | 2024-01-29 |
| 2024-02-12 | S, sale reported on Form 4 | 481 | $185.7K | 2024-02-13 |
| 2024-02-27 | S, sale reported on Form 4 | 843 | $325.8K | 2024-02-27 |
| 2024-03-01 | S, sale reported on Form 4 | 1,605 | $615.5K | 2024-03-01 |
| 2024-04-23 | S, sale reported on Form 4 | 2,818 | $1.0M | 2024-04-24 |
| 2024-04-23 | S, sale reported on Form 4 | 2,500 | $926.7K | 2024-04-24 |
| 2024-07-23 | S, sale reported on Form 4 | 2,818 | $1.3M | 2024-07-24 |
| 2024-11-12 | S, sale reported on Form 4 | 2,199 | $1.2M | 2024-11-13 |
| 2024-11-12 | S, sale reported on Form 4 | 4,010 | $2.1M | 2024-11-13 |
| 2024-11-12 | S, sale reported on Form 4 | 2,257 | $1.2M | 2024-11-13 |
| 2024-11-12 | S, sale reported on Form 4 | 5,000 | $2.7M | 2024-11-13 |
| 2025-02-11 | S, sale reported on Form 4 | 408 | $240.6K | 2025-02-11 |
| 2025-02-27 | S, sale reported on Form 4 | 2,401 | $1.4M | 2025-02-27 |
| 2025-03-03 | S, sale reported on Form 4 | 3,031 | $1.7M | 2025-03-03 |
| 2025-04-25 | S, sale reported on Form 4 | 4,000 | $2.1M | 2025-04-28 |
| 2025-07-25 | S, sale reported on Form 4 | 4,500 | $2.2M | 2025-07-25 |
| 2025-10-28 | S, sale reported on Form 4 | 5,030 | $2.8M | 2025-10-29 |
| 2025-10-28 | S, sale reported on Form 4 | 1,153 | $632.3K | 2025-10-29 |
| 2025-10-28 | S, sale reported on Form 4 | 1,379 | $756.3K | 2025-10-29 |
| 2025-10-29 | S, sale reported on Form 4 | 125 | $67.9K | 2025-10-29 |
| 2025-11-10 | S, sale reported on Form 4 | 105 | $58.8K | 2025-11-12 |
| 2025-12-01 | S, sale reported on Form 4 | 125 | $71.1K | 2025-12-02 |
| 2025-12-10 | S, sale reported on Form 4 | 104 | $58.2K | 2025-12-10 |
| 2026-01-27 | S, sale reported on Form 4 | 105 | $55.9K | 2026-01-28 |
| 2026-01-27 | S, sale reported on Form 4 | 125 | $66.6K | 2026-01-28 |
| 2026-01-29 | S, sale reported on Form 4 | 126 | $65.5K | 2026-01-30 |
| 2026-02-10 | S, sale reported on Form 4 | 105 | $51.9K | 2026-02-11 |
| 2026-02-11 | S, sale reported on Form 4 | 421 | $208.4K | 2026-02-11 |
| 2026-02-27 | S, sale reported on Form 4 | 2,345 | $1.2M | 2026-03-02 |
| 2026-03-02 | S, sale reported on Form 4 | 125 | $61.6K | 2026-03-03 |
| 2026-03-03 | S, sale reported on Form 4 | 4,728 | $2.3M | 2026-03-03 |
| 2026-03-10 | S, sale reported on Form 4 | 105 | $51.9K | 2026-03-11 |
Stereotaxis, Inc. (STXS)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Inspire Medical Systems, Inc. (INSP)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-03-20 | P, purchase reported on Form 4 | 4 | $655 | 2025-11-24 |
| 2025-04-07 | P, purchase reported on Form 4 | 1 | $148 | 2025-11-24 |
| 2025-05-08 | S, sale reported on Form 4 | 2 | $306 | 2025-11-24 |
| 2025-08-08 | S, sale reported on Form 4 | 4 | $309 | 2025-11-24 |
Nektar Therapeutics (NKTR)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-09-22 | S, sale reported on Form 4 | 3,665 | $65.2K | 2021-09-24 |
| 2022-09-23 | S, sale reported on Form 4 | 4,198 | $13.3K | 2022-09-26 |
| 2023-09-18 | S, sale reported on Form 4 | 4,359 | $3.0K | 2023-09-20 |
Mobia Medical, Inc. (MOBI)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1632901) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms